Загрузка...
Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
At present, the only approved inhaled antipseudomonal antibiotics for chronic pulmonary infections in patients with cystic fibrosis (CF) are nebulized solutions. However, prolonged administration and cleaning times, high administration frequency, and cumbersome delivery technologies with nebulizers...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Mary Ann Liebert, Inc.
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3146747/ https://ncbi.nlm.nih.gov/pubmed/21395432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2010.0855 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|